Company Filing History:
3 out of 163 
3 out of 1,454 
Years Active: 2021-2025
Title: The Innovative Contributions of Bernd Weigle
Introduction
Bernd Weigle, an accomplished inventor based in Ingelheim am Rhein, Germany, is recognized for his significant contributions to the field of biotechnology. With a total of 3 patents to his name, Weigle has made notable advancements in the development of novel drug therapies targeting inflammatory diseases.
Latest Patents
Weigle's latest patents demonstrate his expertise in creating innovative treatments through molecular biology. One of his patents, titled "Nucleic acids encoding polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP," focuses on providing a new type of drug designed to treat subjects suffering from inflammatory diseases. This technology includes polypeptides that comprise at least four immunoglobulin single variable domains (ISVDs), specifically designed so that at least two bind to IL-13 and at least two bind to TSLP. In parallel, another patent titled "Methods of treating asthma with polypeptides targeting IL-13 and TSLP" further emphasizes his dedication to developing effective treatments for asthma by leveraging similar molecular techniques.
Career Highlights
Throughout his career, Bernd Weigle has played key roles in various esteemed companies in the biopharmaceutical sector. Notably, he has contributed to the work at Ablynx N.V. and Sanofi, where his innovative mindset has significantly advanced drug development initiatives. His experience in these organizations has equipped him with a deep understanding of the complexities involved in creating life-changing treatments.
Collaborations
Weigle has collaborated with talented professionals in the field, including coworkers Heidi Rommelaere and Ann Brigé. These collaborations have not only enhanced his research capabilities but have also fostered an environment for innovation through shared expertise and complementary skills.
Conclusion
In summary, Bernd Weigle stands out as a notable inventor with a focus on creating transformative therapies for inflammatory diseases. His latest patents reflect a strong commitment to advancing medical science through innovative solutions. With his background in prestigious companies and fruitful collaborations, Weigle continues to pave the way for future breakthroughs in his field.